Bhushan Akshikar has been appointed as the President of the Organization of Pharmaceutical Producers of India (OPPI) for a two-year term, effective immediately. With years of wide experience in leadership roles at GlaxoSmithKline (GSK), Bhushan Akshikar brings a wealth of knowledge from his work across diverse regions, including India, the Middle East, Russia, the Commonwealth of Independent States, and Africa.
In his previous positions, Bhushan Akshikar has demonstrated a strong commitment to advancing the pharmaceutical sector and fostering innovation. His leadership at GSK has involved overseeing critical operations and strategic initiatives that have contributed to the company’s growth and success in various markets. This experience positions him well to navigate the challenges and opportunities facing the Indian pharmaceutical industry.
As he steps into this new role at OPPI, Bhushan Akshikar aims to enhance collaboration among industry stakeholders and advocate for policies that promote the growth and sustainability of the pharmaceutical sector in India. His strategic vision will be vital in addressing key issues such as access to medicines, regulatory reforms, and research and development.
The appointment of Bhushan Akshikar comes at a pivotal time for OPPI as the organization seeks to strengthen its influence within the pharmaceutical landscape. With a focus on innovation and patient access, Akshikar is set to lead initiatives that will further establish OPPI as a crucial voice for the pharmaceutical industry in India.
